**Core Concept**
Lignocaine (lidocaine) is a Class Ib anti-arrhythmic medication that works by blocking sodium channels, thereby reducing automaticity and slowing conduction velocity in the heart. However, in cases where lignocaine is ineffective, other treatment options must be considered to manage refractory arrhythmias.

**Why the Correct Answer is Right**
In such scenarios, amiodarone is often used as a second-line treatment. Amiodarone has a complex mechanism of action, which includes blocking sodium channels, potassium channels, and calcium channels, as well as enhancing the effects of beta-receptors. This multi-faceted action allows amiodarone to effectively stabilize cardiac membranes and restore normal heart rhythm in patients refractory to lignocaine.

**Why Each Wrong Option is Incorrect**
**Option A:** Digoxin is a Class III anti-arrhythmic medication that works by inhibiting the sodium-potassium ATPase pump, leading to increased vagal tone and decreased automaticity. However, digoxin is not typically used as a second-line treatment for refractory arrhythmias that are not responsive to lignocaine.
**Option B:** Magnesium sulfate is used to treat torsades de pointes and ventricular tachycardia, but it is not a primary treatment for refractory arrhythmias.
**Option C:** Quinidine is a Class Ia anti-arrhythmic medication that works by blocking sodium channels, but it has a narrow therapeutic index and is not typically used as a second-line treatment for refractory arrhythmias.

**Clinical Pearl / High-Yield Fact**
Remember that amiodarone is often used in the management of refractory arrhythmias, particularly ventricular tachycardia and fibrillation, due to its unique mechanism of action and effectiveness in restoring normal heart rhythm.

**Correct Answer: D. Amiodarone**